In the clinical field, few studies have reported the clinical value of CDC42 in inflammation-mediate diseases, while only one study reported that CDC42 expression was reduced in activate IBD pediatric patients compared to controls; also it correlated with activate status of pediatric IBD [16]. Here, CDC42 is linked to inflammatory bowel disease.